Skip to main navigation Skip to search Skip to main content

Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms

  • Richard P. Baum
  • , Harshad R. Kulkarni
  • , Aviral Singh
  • , Daniel Kaemmerer
  • , Dirk Mueller
  • , Vikas Prasad
  • , Merten Hommann
  • , Franz C. Robiller
  • , Karin Niepsch
  • , Franz Holger
  • , Arthur Jochems
  • , Philippe Lambin
  • , Dieter Horsch*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

96 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science